Université Paris Sud/Saclay, Faculté de Médecine, Kremlin Bicêtre, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Institute, Villejuif, France; Equipe 11, UMRS1138 INSERM, Centre de Recherche des Cordeliers, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Sorbonne Université, Paris, France.
Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Institute, Villejuif, France; Equipe 11, UMRS1138 INSERM, Centre de Recherche des Cordeliers, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Sorbonne Université, Paris, France; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France; Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
Int Rev Cell Mol Biol. 2018;337:49-81. doi: 10.1016/bs.ircmb.2017.12.006. Epub 2018 Feb 12.
In less than a decade, organoid systems have emerged as an innovative and valid in vitro method to mimic in vivo pathophysiology. Organoids are 3D structures constituted by multiple organ-specific cell types that self-organize and can function as miniature organs. Organoids have quickly become an important tool for basic and translational research with wide applications for disease modeling, drug screening, drug optimization, and personalized and regenerative medicine. In this review, we summarize the recent utilization of organoids for modeling human genetic diseases, a research area with promising biomedical applications.
在不到十年的时间里,类器官系统已经成为一种创新且有效的体外方法,可以模拟体内生理病理。类器官是由多种器官特异性细胞类型自组织形成的 3D 结构,可以作为微型器官发挥功能。类器官已经迅速成为基础和转化研究的重要工具,广泛应用于疾病建模、药物筛选、药物优化以及个性化和再生医学。在这篇综述中,我们总结了类器官在人类遗传疾病建模方面的最新应用,这是一个具有广阔生物医学应用前景的研究领域。